TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
RCUS

Arcus Biosciences Inc

Healthcare · Biotechnology

25.20$ -1.2% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Arcus Biosciences Inc (RCUS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 247 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement RCUS
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
0.0 1.4 8.4 15 78 383 112 117 258 247
1.3 2.6 50 78 159 7.1 14 340 10 10
-1.3 1.4 8.4 15 78 383 112 117 258 237
14 47 50 78 159 257 288 340 448 523
3.9 7.6 14 25 43 72 104 117 120 110
17 55 63 104 202 329 392 457 588 623
-18 -53 -55 -89 -124 54 -280 -340 -330 -386
0.0 0.0 4.9 0.0 0.0 0.3 2.0 2.0 4.0 8.0
-18 -53 -50 -85 -123 55 -266 -301 -283 -353
0.0 0.0 5.3 -8.8 -6.2 2.0 1.0 6.0 1.0
-18 -53 -50 -76 -123 53 -267 -307 -283 -353
-17 -51 -51 -85 -120 59 -258 -291 -269 -335

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?